(Q43138872)

14 November 2017

Hepatitis B reactivation related to everolimus (English)

1 reference

14 November 2017

Sema Sezgin Göksu

1

1 reference

14 November 2017

Serife Bilal

series ordinal

2

1 reference

14 November 2017

Hasan Şenol Coşkun

series ordinal

3

1 reference

14 November 2017

1 January 2013

1 reference

World Journal of Hepatology

14 November 2017

1 reference

14 November 2017

5

1 reference

14 November 2017

1

1 reference

14 November 2017

43-45

1 reference

Reactivation of hepatitis B virus and hepatitis C virus in patients with cancer

14 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3562726

Current trends in management of hepatitis B virus reactivation in the biologic therapy era

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3562726

Everolimus in clinical practice in long-term liver transplantation: an observational study

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3562726

m-TOR inhibitors: what role in liver transplantation?

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3562726

Reactivation of hepatitis B virus infection after cytotoxic chemotherapy or immunosuppressive therapy

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3562726

Rituximab-associated hepatitis B virus (HBV) reactivation in lymphoproliferative diseases: meta-analysis and examination of FDA safety reports

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3562726

Phase 3 trial of everolimus for metastatic renal cell carcinoma : final results and analysis of prognostic factors

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3562726

Chronic myeloid leukemia patient manifesting fatal hepatitis B virus reactivation during treatment with imatinib rescued by liver transplantation: case report and literature review

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3562726

Systematic review: the effect of preventive lamivudine on hepatitis B reactivation during chemotherapy

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3562726

Prevention of hepatitis B virus reactivation in patients receiving immunosuppressive therapy or chemotherapy

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3562726

Reactivation of hepatitis B virus after glioblastoma treatment with temozolomide--case report

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3562726

Lamivudine for the prevention of hepatitis B virus reactivation in hepatitis B s-antigen seropositive cancer patients undergoing cytotoxic chemotherapy.

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3562726

Gemcitabine and reactivation of hepatitis B.

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3562726

15 August 2018

Identifiers

DOI

10.4254/WJH.V5.I1.43

1 reference

14 November 2017

1 reference

14 November 2017

PubMed publication ID

23383366

1 reference